Stockreport

Capricor (CAPR) Advances in DMD Therapy With Positive Study Data [Yahoo! Finance]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF the ongoing HOPE-2 open-label extension (OLE) study on CAP-1002 for Duchenne muscular dystrophy (DMD). Patients treated with CAP-1002 showed sustained improvements in [Read more]